CCC
CTOR

Cable Car Capital’s Citius Oncology CTOR Stock Holding History

Cable Car Capital’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-125,000
Closed -$1.37M – 61
2023
Q4 		$1.37M Buy
+125,000
New +$1.36M 1.42% 18

Other funds holding CTOR

WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Cable Car Capital's CTOR Position: Q1 2024 in Review

Cable Car Capital sold out of Citius Oncology (CTOR) in Q1 2024, closing a stake of 125,000 shares — an estimated $1.37M sold.

Cable Car Capital first reported a position in CTOR in Q4 2023 and held it in 1 quarter. The position peaked at $1.37M in Q4 2023. 15 funds tracked by Wall St. Rank hold CTOR as of Q1 2024.

  • Cable Car Capital reported no remaining Citius Oncology position as of Q1 2024 after selling out during the quarter.
  • Cable Car Capital sold 125,000 Citius Oncology shares in Q1 2024, an estimated $1.37M.
  • Cable Car Capital first reported a position in Citius Oncology in Q4 2023 and held it in 1 quarter.
  • Cable Car Capital's Citius Oncology position peaked at $1.37M in Q4 2023.
  • 15 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2024.

Based on Cable Car Capital's 13F filing for Q1 2024, filed 15 May 2024.